EGFR AND KRAS MUTATIONS
    7.
    发明申请
    EGFR AND KRAS MUTATIONS 审中-公开
    EGFR和KRAS突变

    公开(公告)号:US20090202989A1

    公开(公告)日:2009-08-13

    申请号:US11915830

    申请日:2006-06-13

    申请人: Kenneth J. Hillan

    发明人: Kenneth J. Hillan

    IPC分类号: C12Q1/68 C12Q1/48

    摘要: The present invention relates to mutations in Epidermal Growth Factor Receptor (EGFR) and KRAS and methods of detecting such mutations as well as prognostic methods method for identifying a tumors that are susceptible to anticancer therapy such as chemotherapy and/or kinase inhibitor treatment. The methods involve determining the presence of a mutated EGFR gene or mutated EGFR protein and/or mutated KRAS gene or protein in a tumor sample.

    摘要翻译: 本发明涉及表皮生长因子受体(EGFR)和KRAS中的突变以及检测这些突变的方法以及用于鉴定对抗癌疗法如化疗和/或激酶抑制剂治疗敏感的肿瘤的预后方法。 所述方法包括确定肿瘤样品中突变的EGFR基因或突变的EGFR蛋白和/或突变的KRAS基因或蛋白质的存在。